Nationwide Children's Hospital
3 clinical trials · 3 recruiting · OTHER
Trials by Nationwide Children's Hospital
RECRUITINGPhase 2NCT06838676
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
This is a Phase II open-label study to investigate the safety and efficacy of ACT001 in patients with DIPG and H3K27-altered HGG.
Sponsor: Nationwide Children's HospitalEnrolling: 6020 locations
Diffuse Intrinsic Pontine Gliomas (DIPG)Progressive DIPGRefractory DIPG+2
RECRUITINGNCT03622359
Radiotracer-Based Perfusion Imaging of Patients With Peripheral Arterial Disease
The aim of this clinical study is to 1) establish a healthy database for nuclear perfusion imaging of the lower extremities and 2) assess the prognostic value of radiotracer-based...
Sponsor: Nationwide Children's HospitalEnrolling: 1921 location
Peripheral Artery DiseaseDiabetes MellitusChronic Limb-Threatening Ischemia
RECRUITINGNCT06264700
Applying Directly Observed Therapy to Hydroxyurea to Realize Effectiveness
This study is for caregivers of young children with sickle cell disease and adolescents with sickle cell disease who are currently prescribed hydroxyurea and are receiving care at...
Sponsor: Nationwide Children's HospitalEnrolling: 603 locations
Sickle Cell Disease